Another recent report in T1DM patients from the Scottish Diabetes Research Network Type 1 Bioresource (SDRNT1BIO) and the Finnish Diabetic Nephropathy (FinnDiane) study showed that just the serum KIM-1, as well as CD27, contained most of the predictive information for eGFR progression among a large set of associated biomarkers evaluated with the Luminex platform and LC electrospray tandem MS (LC-MS/MS) (90). This evidence concerns the gene HAVCR1 and type 1 diabetes mellitus.